CD8A and neoplasm: Interestingly, the percentage of CD45+ CD3+ CD8+ T cells (CD8+ TILs) in the tumor tissues was significantly higher in mice treated with UPs-4T1/EPB nanovaccine plus DMXAA than in other groups (Figures 6E, F).